Luminex Corporation recalls ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469
- Recall date
- February 20, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2286-2019
- FDA classification
- Class II
- Brand / firm
- Luminex Corporation
- Sold / distributed
- US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom
Why it was recalled
Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469
Get recall alerts
Free email alert whenever Luminex Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Luminex Corporation